Medicare to Cover Blockbuster Obesity Drugs

(MedPage Today) — Medicare will cover semaglutide (Wegovy) and tirzepatide (Zepbound) for their weight management indications for people with obesity, President Trump announced on Thursday.
As part of a new deal with the White House, doses of…